Zhaoke Ophthalmology Limited

HKSE 6622.HK

Zhaoke Ophthalmology Limited Gross Profit Margin for the year ending December 31, 2023: 75.98%

Zhaoke Ophthalmology Limited Gross Profit Margin is 75.98% for the year ending December 31, 2023. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

HKSE: 6622.HK

Zhaoke Ophthalmology Limited

CEO	Dr. Xiaoyi Li Ph.D.
IPO Date	April 29, 2021
Location	China
Headquarters	No. 1 Meide 3rd Road
Employees	297
Sector	Health Care
Industries Pharmaceuticals Eyewear

Description

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, and commercialization of therapies that address unmet medical needs in the People's Republic of China. It is developing various drugs that cover ophthalmic indications affecting the anterior and posterior segments, including dry eye diseases, wet age-related macular degeneration, diabetic macular edema, myopia, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People's Republic of China.

Key trends

Past 5 years